PKCδ and MAPK mediate G1 arrest induced by PMA in SKBR-3 breast cancer cells
PKCδ and MAPK mediate G1 arrest induced by PMA in SKBR-3 breast cancer cells
复制标题
DOI:
10.1016/j.bbrc.2004.12.070
复制
发表时间:
2005-02
影响因子:
3.1
通讯作者:
G. Yokoyama;T. Fujii;K. Tayama;H. Yamana;M. Kuwano;K. Shirouzu
中科院分区:
文献类型:
--
作者:
G. Yokoyama;T. Fujii;K. Tayama;H. Yamana;M. Kuwano;K. Shirouzu
The effects of activating endogenous protein kinase C (PKC) on cell proliferation and the cell cycle were investigated by treating the breast cancer cell line SKBR-3 with phorbol 12-myristate 13 acetate (PMA). This inhibited cell growth in a concentration-dependent manner, causing a marked arrest of cells in G1. Pre-treatment with GF109203X completely blocked the antiproliferative effect of PMA, and pre-treatment with the PKCδ inhibitor rottlerin partially blocked it. Infecting SKBR-3 cells with an adenovirus vector containing wild-type PKCδ, WTPKCδAdV, had similar effects on PMA. Infecting the cells with a dominant-negative PKCδAdV construct blocked the growth inhibition induced by PMA. Downstream of PKC, PMA treatment inhibited extracellular signal-regulated kinase mitogen-activated protein kinase phosphorylation, up-regulated c-jun NH2-terminal kinase phosphorylation, and inhibited retinoblastoma (Rb) phosphorylation. These results strongly implicated PKC (mainly PKCδ) in the G1arrest induced by PMA and suggested PKC as a target for breast cancer treatment.